Trump unveils discounted drug platform claiming to cut patient costs [MSNBC.com]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: MSNBC.com
TrumpRx.gov, President Donald Trump’s new self-pay prescription drug website, launched Thursday, offering discounted cash prices on 43 brand-name medications.The administration has promoted the platform as a way to cut costs for patients.“You’re going to save a fortune,” Trump said at a White House news conference Thursday evening launching the website. “And this is also so good for overall health care.”Experts, however, saythe biggest savings are likely to be limited to people who are uninsuredThe cost of health care, including prescription drugs, is the top economic concern for most U.S adults, according toa recent poll by KFFAt least 16 drugmakers have negotiated agreements with the White House to participate on the platform. The discount prices are part of Trump’s broader effort to implement a “most favored nation” pricing model for prescription drugs, meaning the U.S. pays no more than the lowest prices charged in other wealthy countries.As of Thursday, the site included discount
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly: Positives Outweigh The Concerns [Seeking Alpha]Seeking Alpha
- ELI LILLY AND COMPANY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Eli Lilly and Company’s Directors and Officers for Breach of Fiduciary Duties – LLYBusiness Wire
- Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at JPMorgan Chase & Co. from $1,150.00 to $1,300.00. They now have an "overweight" rating on the stock.MarketBeat
- Eli Lilly and Company (NYSE:LLY) was given a new $1,281.00 price target on by analysts at Truist Financial Corporation.MarketBeat
- Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at Scotiabank.MarketBeat
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 2/4/26 - Form 8-K
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- LLY's page on the SEC website